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Disclaimer 
 
 
Certain commercial equipment, instruments, and materials are identified in 
this report to specify adequately the experimental procedure. In no case does such identification 
imply recommendation or endorsement by the European Commission, nor does it imply that the 
material or equipment is necessarily the best available for the purpose. 
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Abstract 
 
This report describes the certification of a reference material (IRMM-351) of Escherichia coli 
O157. Certified Reference Materials (CRMs) for microbiological analysis are indispensable 
tools for development and validation of detection methods and for the implementation and 
support of internal and external quality control in the area of microbiological analysis. Each 
vial contains one material sphere of E. coli O157. The homogeneity and stability (at 4 °C, -20 
°C and -70 °C) of the batch was assessed by monitoring colony forming units (cfu) on 
nutrient agar (NA) and enterohemolysin agar (EhlyA) of selected vials by colony counting. 
The material is not stable at 4 °C but no instability was detected when stored at -20 °C for up 
to 12 months and at -70 °C for up to 54 months. The batch was characterised by six 
laboratories to determine a certified value of cfu per vial on NA and EhlyA. The certified value 
is 4 cfu on both agars with an expanded uncertainty of 2 using a coverage factor k = 2, 
corresponding to a level of confidence of about 95%. DNA sequence analysis of the coding 
region for the fliC gene identified the material as E. coli O157.  
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Glossary 
ANOVA   analysis of variance 
BLAST    Basic Local Alignment Search Tool 
bp    base pair 
cdg    degradation rate 
cfu    colony forming unit 
CRM    Certified Reference Material 
DTCS    dye terminator cycle sequencing  
dNTP    deoxynucleotide triphosphate 
DNA    deoxyribonucleic acid 
EhlyA    enterohemolysin agar 
fliC1    gene encoding flagellin 
if     number fraction 
gDNA    genomic DNA 
i    number of cfu in object class 
icert    certified cfu value 
iend    mean cfu value at the end of stability monitoring at -70 °C 
iest    mean cfu value at the end of the expected shelf-life 
i char    mean cfu value for characterisation 
i hom    mean cfu value for homogeneity 
IRMM    Institute for Reference Materials and Measurements 
k    coverage factor 
LTS    long term stability  
M    batch size 
m    sample size 
m.p.n.    most probable number 
N    total number of vials in the homogeneity study 
n    total number of replicates 
NA    nutrient agar 
NCTC    national collection of type cultures 
P    probability of the distribution 
PC    post certification 
PCR    polymerase chain reaction 
p    experimental probability 
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pi    experimental probability in object class i 
RM    reference material 
RSD    relative standard deviation 
s    standard deviation 
STS    short term stability  
studytΔ     duration of the study 
shelft     expected shelf-life 
U    expanded uncertainty 
u    standard uncertainty 
x     mean 
 
                                                                                                                                                        
1 Following international nomenclature, three-letter non-italic codes with a capital letter at the 
beginning refer to the protein, whereas lowercase italic letters are used for the genes 
 6  
 7  
1 Introduction  
Certified Reference Materials (CRMs) for microbiological analysis are indispensable tools for 
development and validation of detection methods and for the implementation and support of 
internal and external quality control in the area of microbiological analysis. IRMM offers 
already microbiological RMs with certified colony forming unit (cfu) numbers per matrix unit 
covering six different food and water micro-organisms (annex 1). Statistical effects, such as 
Poisson distribution at low cfu numbers, encouraged us to consider alternative approaches 
for development and certification of reference materials. IRMM currently extends the range of 
CRMs to more micro-organisms with relevant cfu counts, including Escherichia coli O157 at 
a level of 4 cfu per material sphere, or new CRMs at a level of 1000 cfu per material sphere 
for water control laboratories.  
This report describes the certification of a batch of 770 vials (IRMM-351) containing E. coli 
O157 at a level of 4 cfu per material sphere. Homogeneity and stability of the produced batch 
were analysed at IRMM following IRMM RM Unit procedures applying a quality management 
system according to ISO Guide 34 [1-4]. Batch characterisation was performed by IRMM and 
five external laboratories. The procedures used for the batch characterisation as well as for 
homogeneity and stability testing were colony counting on nutrient agar (NA) and 
enterohemolysin agar (EhlyA) according to ISO 7218 [5] and ISO 16654 [6], respectively.  
Identification of E. coli O157 was performed by DNA sequence analysis of the fliC gene 
encoding flagellin (filament structural protein of flagella). 
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2 Participants  
 
The reference material was developed and produced by BTF Pty Ltd. (North Ryde, AU). 
Analysis of homogeneity and stability and additional characterisation of IRMM-351 was 
performed at IRMM. Participants for batch characterisation measurements were:  
- IRMM, Joint Research Centre, European Commission, Geel, BE 
- CCFRA Technology Ltd, Gloucestershire, GB 
- TNO Quality of Life, Zeist, NL 
- Animal Sciences Group, Lelystad, NL 
- Institut Pasteur de Lille, Lille, FR 
- Food and Consumer Product Safety Authority, Zutphen, NL 
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3 Processing steps 
IRMM-351 was produced at BTF Pty Ltd. (North Ryde, AU) in the BioBallTM format [7]. For 
the production, a modified flow cytometer was used. The latter allows the sorting and 
counting of a number of bacterial cells into a single droplet. For the reference material 
discussed here the target value was set at 5 cells per droplet. In a second step the droplet 
was collected in a glass vial with liquid nitrogen resulting in a frozen ball. Finally the ball was 
freeze-dried using a lyoprotectant consisting of a protein-carbohydrate matrix. This 
lyoprotectant allows a maximal viability of the bacterial cells in the material sphere. Glass 
vials were closed with a rubber stopper and stored at -70 °C until analysis. In total, 770 vials 
of IRMM-351 were produced.  
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4 Procedures 
4.1 Minimum sample volume  
One material sphere is used per assay. 
4.2 Colony counting  
One material sphere was reconstituted as described in section 10.2. Colony counting was 
performed on NA according to ISO 7218 [5] and on EhlyA according to ISO 16654 [6]. Plates 
were incubated at 37 °C for 17 to 22 h. 
4.3 PCR 
Each reaction mixture for PCR reactions (25 μL total volume) contained PCR buffer (20 mM 
Tris-HCl (pH 8.4), 50 mM KCl), 1.5 mmol/L MgCl2, 200 μmol/L dNTP, 0.4 μmol/L forward 
primer, 0.4 μmol/L reverse primer, 1 unit Platinum® Taq DNA polymerase. As a template for 
the PCR reaction part of one bacterial colony was used. PCR primers used are summarised 
in Table 1. All other reaction components for PCR reactions were provided by Invitrogen 
(Merelbeke, BE). PCR reactions were performed using the following time programme: 
denaturation genomic DNA (gDNA) at 94 °C for 5 min; 35 cycles denaturation 94 °C for 30 s, 
annealing 60 °C for 30 s, extension 72 °C for 30 s; incubation 72 °C for 5 min; hold 4 °C. 
PCR products were visualised by agarose gel electrophoresis. 
 
Table 1. Primers used for qualitative PCR. 
Organism PCR target, amplicon 
length 
Primer DNA sequence Reference 
E. coli O157 EDL933 fliC gene, 625 bp fliCh7-F 
fliCh7-R 
5'-GCG CTG TCG AGT TCT ATC GAG C-3' 
5'-CAA CGG TGA CTT TAT CGC CAT TCC-3' 
[8] 
 
4.4 DNA sequencing 
PCR products (25 μL), amplified with primers fliCh7-F and  
fiCh7-R, were purified using the QiaQuick® PCR Purification Kit (Qiagen, Venlo, NL) and 
cloned into pCR2.1 (Invitrogen, Merelbeke, BE). Plasmid DNA was purified using the 
QIAprep Spin Miniprep Kit (Qiagen, Venlo, NL). Purified plasmid DNA was used in the dye 
terminator cycle sequencing (DTCS) reaction, according to the DTCS chemistry protocol [9]. 
Samples were analysed on a CEQ™ 8000 genetic analysis system (Beckman Coulter, Inc., 
Fullerton, CA, US), using the following method: denaturation 120 s at 90 ºC, injection 15 s at 
2.0 kV, separation 85.0 min at 4.2 kV. As a control for the sequencing reaction the CEQ8000 
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pUC18 plasmid was included on each sequencing plate. Validation of DNA sequencing using 
the CEQ8000 system is described in detail in ref [10]. 
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5 Homogeneity and characterisation of the batch 
The measurand in this certification project is the number of cfu per material sphere. Since cfu 
is a discrete variable and numbers are small, the commonly accepted CRM strategies for 
continuous variables which extensively use analysis of variance (ANOVA) are not applicable. 
Moreover, there is no difference in the procedure used for homogeneity testing and batch 
characterisation. Therefore, an approach treating homogeneity test results and 
characterisation results on an equal level was implemented.   
5.1 Planning and results of homogeneity study 
770 vials were produced and the total number of vials to be used in the homogeneity study 
(N) was calculated from 3√ 770 = 9.17 [2]. Because of the high relative standard deviation 
(RSD%) obtained for low cfu values, the number of vials in the homogeneity study was 
increased to 30 per procedure. For each analysis the sample intake was one material sphere 
i.e. n = 1 measurement per vial. Vials for the homogeneity study were taken from the stock at 
-70 °C. Cfu values per material sphere were determined by plating and colony counting on 
NA, according to ISO 7218 [5] and on EhlyA, according to ISO16654 [6]. Samples were 
incubated at 37 °C for 17 to 22 h. The results of the homogeneity measurements are 
summarised in Table 2. 
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Table 2. Measurement data for the homogeneity study of IRMM-351 (n = 1). Individual data per 
vial as well as the mean ( x ), standard deviation (s) and relative standard deviation (RSD%) are 
shown for both agars. 
NA EhlyA 
Vial 
identification 
number 
Measured value 
(cfu) 
Vial 
identification 
number 
Measured value 
(cfu) 
18 6 17 6 
44 5 43 3 
64 3 45 4 
100 2 65 6 
122 3 101 3 
143 1 124 4 
151 3 139 5 
182 4 150 6 
224 5 157 7 
250 5 192 4 
271 4 228 6 
289 5 269 3 
304 5 339 2 
341 5 374 5 
372 5 382 4 
381 6 408 5 
423 3 417 4 
432 1 456 5 
451 4 489 4 
480 2 493 5 
517 4 537 2 
538 3 561 4 
564 4 566 3 
586 3 589 4 
621 3 623 4 
646 3 645 3 
657 5 656 3 
694 3 702 4 
706 4 710 3 
735 4 738 5 
x  3.8 x  4.2 
s 1.3 s 1.2 
RSD% 35 RSD% 30 
 
5.2 Planning and results of batch characterisation study 
The batch of IRMM-351 was characterised by six laboratories by plating and colony counting 
of 15 vials on NA, according to ISO 7218 [5] and 15 vials on EhlyA, according to ISO 16654 
[6]. Results of these measurements are summarised in Table 3. 
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Table 3. Measurement data for batch characterisation of IRMM-351. Individual data per vial as 
well as the mean ( x ), standard deviation (s) and relative standard deviation (RSD%) are shown 
for both agars. Suspicious data (sets) are highlighted in gray.  
 
A. NA 
 Measured value (cfu) 
Vial no Lab 1 Lab 2 Lab 3 Lab 4 Lab 5 Lab 6 
1 6 4 2 1 5 3
2 5 2 0 4 4 300
3 3 4 2 4 4 5
4 2 1 1 3 6 2
5 3 2 2 4 4 3
6 1 5 0 2 3 4
7 3 2 2 5 2 5
8 4 7 4 1 3 5
9 5 5 5 3 4 5
10 5 2 2 2 3 5
11 4 2 5 4 4 5
12 5 6 3 5 4 3
13 5 5 2 5 3 2
14 5 4 6 3 5 8
15 5 3 4 2 4 2
x  4.1 3.6 2.7 3.2 3.9 4.1
s 1.4 1.8 1.8 1.4 1.0 1.7
RSD% 34 49 67 43 26 41
 
B. EhlyA 
 Measured value (cfu) 
Vial no Lab 1 Lab 2 Lab 3 Lab 4 Lab 5 Lab 6 
1 3 3 5 2 3 3
2 5 4 5 6 4 2
3 3 1 3 6 3 2
4 2 4 3 3 1 2
5 4 5 3 4 4 3
6 6 4 3 4 6 2
7 6 3 3 5 3 2
8 6 7 4 4 4 3
9 4 6 4 3 1 10
10 6 5 4 3 3 3
11 2 4 3 6 0 3
12 4 5 5 7 5 3
13 1 2 1 4 4 3
14 5 2 5 7 3 3
15 4 4 4 5 3 3
x  4.1 3.9 3.7 4.6 3.1 3.1
s 1.6 1.6 1.1 1.6 1.6 2.0
RSD% 40 40 30 34 50 63
 
 15  
5.3 Evaluation of homogeneity and batch characterisation studies 
5.3.1 Outliers 
No suspicious data were detected for the homogeneity study based on the interval of 
observed cfu values which corresponds well to the data interval obtained by the producer 
BTF (data not shown). Moreover no values of 0 cfu were obtained. Therefore the complete 
set of data from the homogeneity study was used.  
For the batch characterisation study on NA, one suspicious data set was detected. Data from 
Lab 3 included two cfu values of 0, showed a low mean cfu and a RSD% equalling twice the 
RSD% as obtained by BTF. This laboratory used the same agar composition and supplier as 
Lab 6 and should therefore have obtained similar data. Moreover 0 cfu values are considered 
to be technically unlikely since production of the material spheres is performed with a flow 
cytometer. Therefore, we excluded this data set on a technical basis. Data sets from other 
laboratories were used as such except for 2 outlying values of Lab 6 highlighted in gray. The 
value of 300 cfu in the data set on NA was considered as a laboratory error (contamination). 
The value of 10 cfu in the data set on EhlyA was suspected as an outlier. Inclusion or 
exclusion of this value will be based on comparison of the analysis of all data with and 
without the suspected outlying value (see section 5.3.3). 
5.3.2 Statistical distribution 
To analyse the data based on an appropriate statistical distribution three general limitations 
have to be considered: 
1) The underlying true distribution is unknown. The normal distribution is not applicable 
since it is used for continuous data or as the extreme limit of the Poisson distribution in case 
of large means. The Poisson distribution itself is used for discrete data and is often used as a 
model for the number of events. However the prerequisite for applying the Poisson 
distribution is that the number of events is very large and the probability of event occurrence 
is very small such that their product approaches a constant value [11]. For the CRM 
discussed here this requirement is not met.  
If the statistical distribution is known, main questions are related to the composition of the 
sample and the probability of the occurrence of a certain composition, given the batch 
composition and the sample size. In case of an unknown statistical distribution, one asks 
how the batch is composed, given the sample size and its composition. 
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2) No repeatability estimate is available due to the impossibility of doing replicate analyses 
on the same vial.  
3) ANOVA is not well-developed for statistical distributions other than the normal distribution 
and Poisson distribution, and it is fuzzy due to the (comparably) large variances obtained for 
a small number of vials. Therefore, following the procedures as described in ISO Guide 35 
(which use ANOVA for deriving the major uncertainty contributions such as repeatability, 
laboratory and method bias) is not reasonable.  
As a consequence of the above mentioned limitations, models are needed to find an 
appropriate way to analyse the data. The most obvious is to consider sampling distributions 
for random discrete variables. These assume a reservoir of objects with a property which can 
take only a limited number of values (at least 2). The hypergeometric distribution was 
proposed [11].  Using this model the procedure is considered error-free. All influences of the 
procedure are transferred to the batch. The batch has M objects, all having the property of 
containing i cfu. The number of cfu can take several values (e.g. 3, 4, 5 and 6). One takes 
samples of m units at random from the batch without replacement and expects to obtain the 
hypergeometric distribution. One alters the fraction of units containing 3, 4, 5, etc cfu in the 
batch to obtain the best fit to the experimental distribution.  
5.3.3 Implementation of the hypergeometric distribution 
Tested vials from the homogeneity tests and the batch characterisation all contain a cfu 
number from 0 to 10. Each different cfu number represents a different object class i. 
Therefore i is set at i = 0 to i = 10. No other object classes were assumed for the batch than 
those observed for the vials of homogeneity and batch characterisation tests.  
The number of vials with i cfu are given in Table 4. The experimental probability (pi) of 
frequency of vials in a certain object class i was calculated based on the number of tested 
vials. This value was multiplied by the batch size to obtain the most probable numbers 
(m.p.n.) of vials per object class. The probability (P) of this sample pattern or distribution is 
(relatively) small due to the considerable number of combinations from several classes. The 
P was maximised by altering the fractions of the objects in the different classes in the batch 
(using the MS-Excel® solver function). This resulted in the final numbers for the batch.  
Taking into account the proportion of the sample size (m) to the batch size (M), one obtains 
an estimate and a variance for the number fraction if  of each object class i in the batch. 
The mean cfu estimate for the batch ( i ) is then calculated according to equation (1) where i 
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is the number of cfu in an object class and if is the number fraction of this object class in the 
batch.  
m
fi
i i
i∑ ⋅
=     (1) 
The u is calculated by equation (2) where u ( if ) is the square root of the variance estimate 
for if  obtained from the hypergeometric distribution.  
∑ ⋅=
i
ifuiiu )()(
22   (2) 
Calculations using the hypergeometric distribution can be found in Table 4A (homogeneity) 
and Table 4B (batch characterisation). Results are given separately for colony counting on 
NA and colony counting on EhlyA. For analysis of batch characterisation data, the batch size 
was decreased by 120 units taking into account the removal of 60 units each for the sample 
size of homogeneity and stability studies. Batch characterisation data sets of different 
laboratories were in the same data interval and were obtained with the same procedure. 
Since the procedure is considered error-free in the hypergeometric distribution model, these 
data sets were pooled thereby increasing the sample size for statistical analysis.  It was 
observed that the optimised probabilities P for the distributions containing or not containing 
the suspected outlier of 10 cfu differed considerably by a factor of nearly 8. Therefore, this 
value was excluded.  
 
 18  
Table 4. Statistical analysis of homogeneity and batch characterisation data 
A. Homogeneity 
E. coli on NA  batch size 770         
  sample size 30         
             
i 0 1 2 3 4 5 6 7 8 9 10 total 
                          
number of vials with i cfu 0 2 2 9 7 8 2 0 0 0 0 30 
             
experimental pi 0 0.07 0.07 0.30 0.23 0.27 0.07 0 0 0 0   
m.p.n. in class i  0 51.3 51.3 231 180 205 51.3 0 0 0 0 770 
P of this distribution 0.000826                   
final numbers   51 51 232 181 205 50 0 0 0 0 770 
             
number fraction fi 0 1.99 1.99 9.04 7.05 7.99 1.95 0 0 0 0   
variance for fi 0 1.34 1.34 2.47 2.28 2.37 1.32 0 0 0 0   
                          
mean cfu ( i hom)  3.76 
uhom  0.63 
 
E. coli on EhlyA  batch size 770         
  sample size 30         
             
i 0 1 2 3 4 5 6 7 8 9 10 total 
                          
number of vials with i cfu 0 0 2 7 10 6 4 1 0 0 0 30 
             
experimental pi 0 0.00 0.07 0.23 0.33 0.20 0.13 0.03 0 0 0   
m.p.n. in class i  0 0.0 51.3 180 257 154 103 25.7 0 0 0 770 
P of this distribution 0.000886                   
final numbers     51 180 257 154 103 25 0 0 0 770 
             
number fraction fi 0 0 1.99 7.01 10 6 4.01 0.97 0 0 0   
variance for fi 0 0 1.34 2.27 2.53 2.15 1.83 0.95 0 0 0   
                          
mean cfu ( i hom)  4.20 
uhom  0.70 
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B. Batch characterisation 
E. coli on NA  batch size 650         
  sample size 74         
             
i 0 1 2 3 4 5 6 7 8 9 10 total 
                          
number of vials with i cfu 0 4 13 14 17 21 3 1 1 0 0 74 
             
experimental pi 0 0.05 0.18 0.19 0.23 0.28 0.04 0.01 0.01 0 0   
m.p.n. in class i  0 35.1 114 123 149 184 26.4 8.78 8.78 0 0 650 
final numbers   35 115 123 149 186 26 8 8 0 0 650 
p of this distribution 0.0000190                   
                          
number fraction fi 0 3.98 13.1 14 17 21.2 2.96 0.91 0.91 0 0   
variance for fi 0 1.83 3.09 3.17 3.41 3.66 1.59 0.89 0.89 0 0   
                          
mean cfu ( i char)  3.75 
uchar  0.39 
 
E. coli on EhlyA  batch size 649         
  sample size 89         
             
i 0 1 2 3 4 5 6 7 8 9 10 total 
                          
number of vials with i cfu 1 5 10 28 21 12 9 3 0 0 0 88 
             
experimental pi 0.01 0.06 0.11 0.31 0.24 0.13 0.10 0.03 0 0 0   
m.p.n. in class i  7.29 36.5 72.9 204 153 87.5 65.6 21.9 0 0 0 648 
final numbers  7 36 73 205 153 88 66 21 0 0 0 648 
p of this distribution 0.00000704                   
                          
number fraction fi  0.96 4.94 10 28.1 21 12.1 9.05 2.88 0 0 0   
variance for fi  0.91 2.01 2.77 4.08 3.72 3 2.65 1.55 0 0 0   
                          
mean cfu ( i char)  3.69 
uchar  0.36 
 
The same procedure is used for homogeneity testing (IRMM) and batch characterisation 
(IRMM and external labs). Consequently homogeneity test and batch characterisation results 
can be treated on an equal level, i.e. the final estimate of the certified value is the simple 
mean of the i  values for homogeneity ( i hom) and batch characterisation ( i char). Final cfu 
values for colony counting on NA as well as EhlyA are given in Table 5.   
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Table 5. Overview of mean cfu values for homogeneity and batch characterisation.  
 NA EhlyA 
Homogeneity ( i hom) 3.76 4.20 
Characteristation ( i char) 3.75 3.69 
Mean 3.76 3.94 
 
The above conclusions are supported by a simplified model comparing the expected and the 
observed probabilities. If one takes a model which assumes a hypergeometric distribution 
with only two possible events (cfu present or absent), and each sample taken comprises 10 
objects (m = 10) corresponding to the artificial object classes, then the full number of 
possible events for a batch size of 770 vials is therefore 770 samples * 10 objects = 7700.  
In Fig. 1A, representing homogeneity and batch characterisation results on NA, the observed 
probabilities for finding 1, 2, 3, … cfu in a sample are displayed separately by columns. 
Given the observed distribution, one may look for parameters of the hypergeometric 
distribution which match it best. This is normally done in a fit procedure which minimises a 
certain criterion. Chi square according to the Kolmogorov criterion is suitable for comparing 
experimental and theoretical distributions, in particular because of it is distribution-
independent. 8 test classes were considered for the Kolmogorov test. Object classes 0 and 
10 were excluded since these values were observed only once. Including them as test 
classes would considerably reduce the power of the Kolmogorov test.   
Minimisation of the statistic of the chi square goodness-of-fit test was done using the MS-
Excel® solver function by altering the p value i.e. the experimental probability of picking an 
object possessing the specified property.  The corresponding hypergeometric distribution 
was plotted and the optimum p value associated with the distribution is used for further 
calculations. Indeed the mean of a hypergeometric distribution is p * m with m being the 
sample size (10 objects). The mean for the batch, 3.83 cfu, agrees well with the values as 
determined above. Likewise, the observed probabilities and hypergeometric distribution for 
homogeneity and batch characterisation results on EhlyA are displayed in Fig. 1B. Again the 
mean for the batch, 3.91 cfu, agrees well with the value in Table 5.  
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Fig. 1: Representation of observed (histograms) and expected (hypergeometric distribution) 
cfu values obtained by colony counting on NA and EhlyA. Mean cfu values are indicated by 
arrows. 
 
A. NA 
B. EhlyA 
3.83 cfu 
p = 0.383 
3.91 cfu 
p = 0.391 
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6 Stability 
6.1 Planning and results of stability study 
The proper conditions for transport of the material to the customer were determined from a 
short term stability (STS) study of vials stored at 4 °C and -20 °C with time points of 0, 1 and 
2 weeks. The stability of the material during storage was determined from long term stability 
(LTS) studies of vials stored at 4 °C  and -20 °C with time points of 0, 3 and 6 months. For 
each temperature/time combination four vials were used. The short term and long term 
stability studies were not carried out in an isochronous way. At the end of an incubation 
period, vials were tested immediately and were not brought back to the storage temperature 
of -70 °C since this shift could possibly have a negative effect on the viability of the bacteria. 
Cfu values per material sphere were determined by colony counting on NA plates after 
incubation at 37 °C for 17–22 h. In parallel with the long term stability study, a 
postcertification (PC) study was started to allow for further monitoring of the stability of the 
batch after certification. Vials were tested at 4 °C and -20 °C at time points of 0, 12, 18 and 
24 months. For each temperature/time combination three vials were used. 
To investigate whether stressing bacteria by storing them at -20 °C results in more difficult 
growth on a selective agar, a long term stability study was carried out at -20 °C with time 
points of 0, 3 and 6 months. As for long term stability on NA, vials were tested immediately 
after each incubation period. For each temperature/time combination four vials were plated 
on EhlyA. The cfu values per material sphere were determined by colony counting.  
Results of stability studies can be found in Tables 6, 7 and 8.  
 
Table 6. STS data of IRMM-351 stored at two different temperatures. At each temperature/time 
combination four vials were tested on NA. Samples for STS were taken at random from the 
batch. t = time in weeks. 
 cfu per material sphere 
temperature (°C) t=0 t=1 t=2 
4 3 5 0
4 2 5 0
4 4 3 2
4 2 2 2
x  2.8 3.8 1 
-20 3 4 4
-20 2 1 3
-20 4 5 1
-20 2 5 4
x  2.8 3.8 3 
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Table 7. LTS data of IRMM-351 stored at two different temperatures. At each temperature/time 
combination four vials were tested. Samples for LTS were taken at random from the batch. t = 
time in months.  
A. NA 
 cfu per material sphere 
temperature (°C) t=0 t=3 t=6 
4 6 2 1
4 3 1 2
4 4 1 4
4 3 3 5
x  4 1.8 3 
-20 6 5 2
-20 3 5 5
-20 4 2 5
-20 3 3 3
x   4 3.8 3.8 
B. EhlyA 
 cfu per material sphere 
temperature (°C) t=0 t=3 t=6 
-20 3 4 4
-20 5 5 4
-20 3 1 3
-20 2 4 3
 x  3.3 3.5 3.5 
Table 8. Available PC data of IRMM-351 stored at two different temperatures. At each 
temperature/time combination three vials were tested. Samples for PC were taken at random 
from the batch. t = time in months.  
 cfu per material sphere 
temperature (°C) t=0 t=12 t=18 
4 7 2 4
4 3 2 0
4 3 2 3
x   4.3 2 2.3 
-20 7 2 4
-20 3 2 4
-20 3 2 2
x   4.3 2 3.3 
 
6.2 Evaluation of stability data 
For assessing stability in this study, one would normally look at the experimental statistical 
distributions obtained at several times and temperatures and decide at which point in time 
these distributions start differing significantly from the hypergeometric distribution obtained 
for the batch. Unfortunately, the low number of vials at each sampling point results in a large 
heterogeneity and variance among the data sets and therefore in large uncertainties. This 
 24  
low number of data points is due to small batch size (770 vials) and the absence of replicate 
analysis.  
Because of the limitations as explained above, data were not plotted but conclusions were 
drawn from the raw data. At 4 °C the material is not stable since two cfu values of 0 were 
found already after 2 weeks. Therefore the material should be shipped frozen. At -20 °C cfu 
values are close to the certified value at any point in time, for NA as well as EhlyA, and the 
material can be stored at -20 °C for at least 6 months. Available data on post-certification 
monitoring at 4 °C and -20 °C, shown in Table 8, support the stability of the material at -20 °C 
for even longer periods of time. At time points of 12 months as well as 18 months, three vials 
for each temperature were analysed. At 18 months, data for -20 °C are still close to the 
certified value. However, an uncertainty estimate has to be included in the final U budget. 
Because of the lack of data at 4 °C and -20 °C, this can only be done based on additional 
data at storage temperature (-70 °C). 
6.3 Stability at storage temperature  
No long term stability study was carried out at the storage temperature (-70 °C) and no 
intermediate sampling points are available. However, after the certification campaign vials 
were taken at random from the batch stored at -70 °C and analysed on NA and EhlyA. 15 
vials were analysed on NA and 26 vials were analysed on EhlyA. The study was non-
isochronous but refers to the initial state as established by the homogeneity test in March 
2006 and the study end point in either November 2007 (NA) or February 2008 (EhlyA). 
Results of the study are given in Table 9 and are presented graphically in Fig. 2 using 
histograms according to the model as described in section 5.3.3. Hypergeometric 
distributions for the start and end point were fitted to the histograms using the minimum 
criterion for the chi square value(s). The distributions are given in the figures for the data 
obtained at the end point of the stability study. It can clearly be seen that changes in the 
distributions occur even at that low storage temperature. The question whether the 
distribution at the end point significantly deviates from the one at the beginning can best be 
answered by looking at the chi square value obtained for a comparison of the end-point 
histogram and the best-fit hypergeometric distribution at the beginning. If this value exceeds 
the critical value (degrees of freedom at the end point are number of test classes – 2, i.e. 6, 
which gives a critical value of 12.6), the observed instability is significant. The corresponding 
chi square values are 6.46 for NA and 15.35 for EhlyA. This means that the observed 
changes are significant on EhlyA agar which is probably explained by the rather high cfu 
values in the homogeneity study. These values are counterintuitive since the bacteria are 
subject to growth pressure on a selective agar and the same or a lower mean cfu value on 
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EhlyA is therefore expected compared to NA. Moreover there are no remarkable 
observations: no values of 0 cfu, no more counts of 1 cfu compared to homogeneity or batch 
characterisation.   
The mean cfu values for the hypergeometric distribution at the end point are calculated from 
the optimum p value (p * m) and are 3.44 cfu on NA and 2.97 cfu on EhlyA.  
 
Table 9. Measurement data for stability monitoring of IRMM-351 at storage temperature (-70 °C). 
Individual data per vial as well as the mean ( x ), standard deviation (s) and relative standard 
deviation (RSD%) are shown for both agars. 
NA EhlyA 
Vial 
identification 
number 
Measured 
value (cfu) 
Vial 
identification 
number 
Measured 
value (cfu) 
Vial 
identification 
number 
Measured 
value (cfu) 
14 3 3 2 655 3 
52 3 4 3 120 3 
85 3 39 3 145 3 
126 2 70 3 294 5 
160 3 115 3 310 5 
387 4 178 2 686 1 
406 4 350 1 716 2 
526 2 390 3 733 1 
546 4 416 3 752 4 
640 2 497 4 762 2 
653 4 520 3 763 4 
676 4 551 3   
719 6 577 6   
746 4 602 4   
771 3 629 3   
x  3.4 x  3.0 
s 1.1 s 1.2 
RSD% 28 RSD% 40 
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Fig. 2: Representation of observed cfu values (histograms) for start and end point data at -70 
°C. The hypergeometric distribution (expected values) is plotted for the end point data. Mean 
cfu values at the end point are indicated by arrows. 
 
A. NA 
B. EhlyA 
3.44 cfu 
p = 0.344 
2.97 cfu 
p = 0.297 
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Because of the relatively low cfu values obtained on EhlyA, only a limited shelf-life can be 
applied. To include an estimate in the final uncertainty budget and to establish a shelf-life, an 
average degradation rate cdg was calculated using the mean cfu for the batch (icert) and the 
mean cfu at the end of the stability study at -70 °C (iend). Assuming that the degradation 
process is governed by an exponential law, cdg is obtained as 
 
study
endcert
dg t
iic Δ
−= )ln()ln(  
where studytΔ  denotes the duration of the study (20 months on NA and 23 months on EhlyA). 
Assuming continuation of this process, the mean cfu content iest at the end of the expected 
shelf-life shelft  (54 months) was calculated according to 
 
shelfdgcertest tcii ⋅−= )ln()ln(  
 
Half of the difference 5.0Δ  between icert and iest fully covers the observed difference. On the 
other hand, both icert and iest have an uncertainty which should be estimated as being not 
smaller than the precision observed in the homogeneity study shom which had been carried 
out under repeatability conditions. Therefore ults was calculated as follows (Table 10): 
hom5.0
2
hom
2
5.0
hom5.0hom 2/
sifsu
sifsu
lts
lts
>Δ−Δ=
≤Δ=  
 
Table 10: Values for icert, iend, cdg, iest, and ults for stability monitoring at -70 °C on NA and EhlyA 
  icert iend cdg iest ults 
NA 3.76 3.44 0.004 2.96 0.44 
EhlyA 3.94 2.97 0.012 2.03 0.66 
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7 Additional characterisation 
 
The DNA sequence of fliC is characteristic for E. coli O157 and can be used for detection, 
identification and discrimination from other E. coli strains [8]. Three random vials from the 
batch were analysed by amplification of the fliC gene by PCR using primers fliCh7-F and 
fliCh7-R. The PCR product was purified and cloned into pCR2.1. Purified plasmid DNA 
containing the amplicon of the fliC gene was purified and used for DTCS using sequencing 
primer M13-Forward (Invitrogen, Merelbeke, BE). The Basic Local Alignment Search Tool 
(BLAST) finds regions of local similarity between sequences. The program compares 
nucleotide or protein sequences to sequence databases and calculates the statistical 
significance of matches. Using nucleotide-nucleotide BLAST the obtained sequence was 
compared to other nucleotide sequences in the GenBank database and showed 100 % 
sequence identity with the reported DNA sequence of the fliC gene of different strains of E. 
coli (Fig. 3).  
 
gi|86604413|emb|AM228904.1|  Escherichia coli O157:H7 fliC gene for flagellin, strain 
NCTC12900 
Length=1758 
 
 Score =  381 bits (192),  Expect = 9e-103 
 Identities = 192/192 (100%), Gaps = 0/192 (0%) 
 Strand=Plus/Plus 
 
Query  87   TGCGCTGTCGAGTTCTATCGAGCGTCTGTCTTCTGGCTTGCGTATTAACAGCGCGAAGGA  146 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  69   TGCGCTGTCGAGTTCTATCGAGCGTCTGTCTTCTGGCTTGCGTATTAACAGCGCGAAGGA  128 
 
Query  147  TGACGCCGCAGGTCAGGCGATTGCTAACCGTTTTACTTCTAACATTAAAGGCCTGACTCA  206 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  129  TGACGCCGCAGGTCAGGCGATTGCTAACCGTTTTACTTCTAACATTAAAGGCCTGACTCA  188 
 
Query  207  GGCGGCCCGTAACGCCAACGACGGTATTTCTGTTGCGCAGACCACCGAAGGCGCGCTGTC  266 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  189  GGCGGCCCGTAACGCCAACGACGGTATTTCTGTTGCGCAGACCACCGAAGGCGCGCTGTC  248 
 
Query  267  CGAAATCAACAA  278 
            |||||||||||| 
Sbjct  249  CGAAATCAACAA  260 
 
Fig. 3 Comparison of the DNA sequence of the fliC amplicon obtained from IRMM-351 (Query) 
with the reported DNA sequence of the fliC gene (Genbank accession no. AM228904) using 
Nucleotide-nucleotide BLAST (blastn) on www.ncbi.nlm.nih.gov. 
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8 Certified values and uncertainties  
8.1 Certified values and uncertainty budget 
Since data are not normally distributed, common ANOVA strategies do not apply. The 
certified number of cfu per material sphere of IRMM-351 was calculated as the mean of the 
mean cfu values in the homogeneity study and batch characterisation. These mean values 
were calculated based on a hypergeometric distribution. The expanded uncertainty (U) of the 
certified value is calculated from the contributing standard uncertainties from 
characterisation, homogeneity test and stability studies using equation (3) and a coverage 
factor k = 2. The uncertainty corresponds to a level of confidence of about 95 %.   
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hom.2 ltscharCRM uuuU ++=  (3)  
Table 11 gives an overview of (rounded) certified values, standard uncertainties and 
expanded uncertainties for colony counting on NA as well as EhlyA. Given the general 
limitation that the measurand can have only integer values, the certified value and 
uncertainty are rounded (upwards) to the closest integer. 
Table 11: Certified values, standard uncertainties (u) and expanded uncertainty (U) for IRMM-
351 on NA and EhlyA 
NA mean u 
homogeneity 3.76 0.63 
characteristation 3.75 0.39 
stability  0.44 
   
total, U at the 95% level 3.76 1.72 
total (rounded, 95%) 4 2 
   
EhlyA mean u 
homogeneity 4.2 0.7 
characteristation 3.69 0.36 
stability  0.66 
   
total, U at the 95% level 3.94 2.04 
total (rounded, 95%) 4 2 
 
8.2 Interpretation and use of the certified values 
If this CRM is used for presence/absence tests, the absolute minimum of samples to be 
analysed should be two. Conclusions should be based on individual cfu values. If the result is 
within the 95% confidence interval specified for the CRM, then the test has been passed, if 
not, it failed.  
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If this CRM is used for method validation or testing of media, a similar approach as for 
certification of the batch should be applied. This requires the measurement of an appropriate 
number of CRM vials, minimum 15 in agreement with the number of CRM vials analysed 
during the characterisation study (section 5.2). Conclusions should be based upon patterns 
(histograms) of the results obtained in the laboratory and during certification rather than on 
mean cfu values. The histogram obtained in the laboratory is compared with the 
hypergeometric distribution obtained for the homogeneity and batch characterisation data 
(section 5.3.3) and a chi square value is calculated. The success of the validation is 
assessed from this chi square value with respect to critical limits. If the lab falls short of the 
critical value, it failed in method validation.  
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9 Metrological traceability 
The certified value (cfu per material sphere) is traceable to the SI unit 1 applying the 
procedures ISO 7218 and ISO 16654. ISO 7218 [5] provides general rules for microbiological 
examinations and ISO 16654 [6] describes a horizontal method for the detection of E. coli 
O157. The sequence identity of the gDNA has been confirmed by DTCS of the fliC gene [8]. 
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10 Instructions for use 
10.1 Dispatch  
Dispatch to the customer must be done at -20 °C. Upon receipt by the customer, the material 
should be used immediately or can be stored at -20 °C or -70 °C. No instability of the 
material was detected when stored at -20 °C for up to 12 months and at -70 °C for up to 54 
months. 
10.2 Instructions for use 
Bacterial samples do not survive at room temperature. Therefore take vials out of the freezer 
one by one during analysis and handle vials with care. Use sterile consumables in all steps 
and work under sterile conditions. 
1. Dry one appropriate media plate per material sphere. 
2. To open the vial containing a material sphere, aseptically remove stopper. 
3. Tip the material sphere into the centre of the plate. Inspect the empty vial and make sure 
no remaining parts of the material sphere are left. 
4. Rehydrate by pipetting 100 µL of 0.9% (m/v) NaCl directly onto the material sphere. Wait 
30 seconds for the material to dissolve. 
5. Use one sterile disposable spreader (no glass spreaders) to evenly spread the dissolved 
material carefully over the plate surface, avoiding the borders of the plate. 
6. Move the end of the spreader lightly up and down on the agar surface 5 times to help 
remove any excess fluid on the spreader. 
7. Dry plates for 30 minutes at room temperature before inverting. 
8. Incubate at appropriate time and temperature.  
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Annex 1: Microbiological CRMs available from IRMM 
BCR-506: Capsules filled with milk powder artificially contaminated by Enterococcus faecium 
(WR 63 / NCTC 13169) 
BCR-507R: Capsules filled with milk powder artificially contaminated by Salmonella 
typhimurium (ALM 40 / NCTC 13171) 
Colony forming particles per capsule / number of negative capsules 
BCR-527: Capsules filled with milk powder artificially contaminated by Enterobacter cloacae 
(WR 3 / NCTC 13168) 
BCR-528: Capsules filled with milk powder artificially contaminated by Bacillus cereus (ATCL 
9139) 
BCR-594: Capsules filled with milk powder artificially contaminated by Escherichia coli (WR 
1 / NCTC 13167) 
BCR-595: Capsules filled with milk powder artificially contaminated by Listeria 
monocytogenes (Scott A) (ALM 92 / NCTC 13173) 
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